UPL snaps up Arysta Life Science for $4.2 billion

Image: arystalifescience.com. FE Bureau Agrochemicals solutions provider UPL, through its wholly-owned subsidiary and international arm UPL Corp, has entered into an agreement with NYSE-listed Platform Specialty Products Corp to acquire Arysta LifeScience Inc and its subsidiaries for approximately $4.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.